Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122823) titled 'Effect of Mongolian Medicine Psychosomatic Interaction Therapy on Emotion and Quality of Life in Patients with Gastrointestinal Cancer Undergoing Chemotherapy' on April 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Inner Mongolia International Mongolian Medical Hospital
Condition:
Gastrointestinal Malignancy
Intervention:
Intervention Group:Mongolian Medicine Mind-Body Interaction Therapy: Group interaction model, 15-20 people per group, once daily for 3 hours, continuous for 28 days. Includes: Opening preparation (music relaxation, Mongolian health exercises), case sharing ...